Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

Representative before the EPO

Employment test 51 - 200 employees
Company dna arnold plus siedsma
operating since 1920
Headquarter in The Hague and 13 offices
active in Legal Services, IP Consulting, IP Portfolio Processing, and IP-related Communication Service

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Company dna saunders and dolleymore llp
no operation time available
2 offices
active in Legal Services

We have observed 12 EP applications Kay Elizabeth Jenkinson has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 20, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12833109

A COMPLIANCE MONITOR

IPC classification:
A61M 15/00, A61M 11/00, G06M 1/00
Applicant:
Adherium (NZ) Limited
Applicant:
Nexus6 Limited
Agent:
James Peter Archibald Cross, Maucher Jenkins
Agent:
Multiple attorneys, Saunders & Dolleymore LLP
Status:
The patent has been granted
EP15180246

ANTI-THROMBOGENIC POROUS MEMBRANES AND METHODS FOR MANUFACTURING SUCH MEMBRANES

IPC classification:
B01D 69/02, A61M 1/36, B01D 63/16
Applicant:
Fenwal Inc
Agent:
Multiple attorneys, Arnold & Siedsma
Status:
APPLICATION PUBLISHED
EP15187181

AUTOMATIC PURGING OF AIR FROM A FLUID PROCESSING SYSTEM

IPC classification:
A61M 5/36, A61M 1/36, A61M 1/34, A61M 1/30
Applicant:
Fenwal Inc
Agent:
Multiple attorneys, Arnold & Siedsma
Status:
EXAMINATION IN PROGRESS
EP15187250

SYSTEMS AND METHODS FOR CONTROLLING THE RETURN PHASE OF A BLOOD SEPARATION PROCEDURE

IPC classification:
A61M 1/26, A61M 5/36, A61M 1/36, A61M 1/34, A61M 1/30
Applicant:
Fenwal Inc
Agent:
Multiple attorneys, Arnold & Siedsma
Status:
EXAMINATION REQUESTED
EP15191472

BLOOD SEPARATION SYSTEM CONTROLLING PLASMA FLOW RATES FOR THERAPEUTIC EXCHANGE PROCEDURES

IPC classification:
B04B 13/00, A61M 1/36
Applicant:
Fenwal Inc
Agent:
Multiple attorneys, Arnold & Siedsma
Status:
The patent has been granted
EP13750820

STIFFENED COMPOSITE PANELS AND METHOD OF THEIR MANUFACTURE

IPC classification:
B29C 70/30, B29D 99/00
Applicant:
The Boeing Company
Agent:
Multiple attorneys, Arnold & Siedsma
Status:
GRANT OF PATENT INTENDED
EP15203259

NON-INVASIVE IDENTIFICATION OF SOLUTIONS

IPC classification:
G01N 33/49, A61M 5/36, A61M 1/36, G01N 21/85
Applicant:
Fenwal Inc
Agent:
Multiple attorneys, Arnold & Siedsma
Status:
EXAMINATION REQUESTED
EP16157558

LIMITING MUSCLE CRAMPS

IPC classification:
G01N 33/84, G01N 33/68, A61B 10/00, A61B 5/145, A61B 5/00, A23L 2/52, A23L 2/39, A23L 2/38
Agent:
Multiple attorneys, Arnold & Siedsma
Status:
EXAMINATION REQUESTED
EP16730315

ADENOVIRUS POLYNUCLEOTIDES AND POLYPEPTIDES

IPC classification:
A61K 39/00, A61K 39/12, C12N 15/861, C07K 14/075, A61K 39/235
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Kay Elizabeth Jenkinson, GlaxoSmithKline
Status:
Request for examination was made
EP16751192

PHARMACEUTICAL COMPOSITION COMPRISING AN ADENOVIRAL VECTOR

IPC classification:
A61K 9/19, A61K 39/235, A61K 47/26
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Kay Elizabeth Jenkinson, GlaxoSmithKline
Status:
Request for examination was made
EP16745090

NOVEL METHODS FOR INDUCING AN IMMUNE RESPONSE

IPC classification:
C07K 14/075, C12N 15/861, C12N 7/00, A61K 39/04
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Kay Elizabeth Jenkinson, GlaxoSmithKline
Status:
Request for examination was made
EP16741946

NOVEL ADENOVIRUS

IPC classification:
C07K 14/075, C12N 15/861, C12N 7/00, A61K 39/04
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Kay Elizabeth Jenkinson, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature